about
Sphingolipids mediate differential echinocandin susceptibility in Candida albicans and Aspergillus nidulans.CRS-MIS in Candida glabrata: sphingolipids modulate echinocandin-Fks interaction.Evaluation of Polymorphic Locus Sequence Typing for Candida glabrata Epidemiology.Fluconazole and Echinocandin Resistance of Candida glabrata Correlates Better with Antifungal Drug Exposure Rather than with MSH2 Mutator Genotype in a French Cohort of Patients Harboring Low Rates of Resistance.Genetic Drivers of Multidrug Resistance in Candida glabrata.Prevalent mutator genotype identified in fungal pathogen Candida glabrata promotes multi-drug resistance.The Gastrointestinal Tract Is a Major Source of Echinocandin Drug Resistance in a Murine Model of Candida glabrata Colonization and Systemic Dissemination.Absence of azole or echinocandin resistance in Candida glabrata isolates in India despite background prevalence of strains with defects in DNA mismatch repair pathway.VT-1598 inhibits the in vitro growth of mucosal Candida strains and protects against fluconazole-susceptible and -resistant oral candidiasis in IL-17 signalling-deficient mice.Multilocus Sequence Typing (MLST) Genotypes of Bloodstream Isolates in Korea: Association With Antifungal Resistance, Mutations in Mismatch Repair Gene (Msh2), and Clinical OutcomesSpontaneous mutational frequency and mutation rates vary by echinocandin agent againstLimited Mutations Identified in Isolates of Candida auris Directly Contribute to Reduced Azole SusceptibilityFungal Resistance to Echinocandins and the MDR Phenomenon inHyperdiploidy with trisomy 9 and deletion of the CDKN2A locus in T-cell acute lymphoblastic leukemiaMolecular Analysis of Resistance and Detection of Non-Wild-Type Strains Using Etest Epidemiological Cutoff Values for Amphotericin B and Echinocandins for Bloodstream Candida Infections from a Tertiary Hospital in Qatar
P50
Q35607760-FEBD81AE-85B5-42BB-A34F-337C37552D6FQ36322437-D879F9EB-57A4-455F-8E06-952E8384E577Q36734976-B5C55E46-1EF9-4746-A93B-356A11606773Q37528498-877F754E-72E1-4F64-B2A0-4C4391C2ACEDQ39065051-F905B3F9-F491-4244-A6F4-2F8FDD6805B4Q40738359-CBFA7C14-ACD4-43A5-8686-648CA59817B5Q46296427-1AD856AE-BB8C-4AF2-A1E6-85EFCD7AF51DQ52611995-8D213A66-0D71-471B-A619-6C1BD8D8A0BDQ54202799-350D950D-D49E-4DFC-A65C-CAD57C01F95CQ57214733-654DFC1B-C4B1-4273-A7F6-1DF3B616BB88Q58100719-D67B1359-BED4-41D1-89E1-A851EB811BE3Q58701183-0498EFDF-37A2-4A14-9C2D-E408B84D1734Q58773579-AC5A004F-5CA3-40D8-A93B-5A3ED67A7BF8Q83689594-E6E429BB-ADAD-48BF-B06A-383D7C99A89BQ89241352-5A29049F-75D2-4535-9007-02884CE4EAE6
P50
description
researcher ORCID ID = 0000-0001-5636-256X
@en
name
Kelley R Healey
@ast
Kelley R Healey
@en
Kelley R Healey
@es
Kelley R Healey
@nl
type
label
Kelley R Healey
@ast
Kelley R Healey
@en
Kelley R Healey
@es
Kelley R Healey
@nl
prefLabel
Kelley R Healey
@ast
Kelley R Healey
@en
Kelley R Healey
@es
Kelley R Healey
@nl
P1153
26434714500
P31
P496
0000-0001-5636-256X